[HTML][HTML] Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy
M Kostinov, O Svitich, A Chuchalin, V Osiptsov… - Scientific Reports, 2024 - nature.com
Mucosal immunity plays a major role not only in the prevention but probably also in the
outcomes of COVID-19. An enhanced production of secretory immunoglobulin A (sIgA) …
outcomes of COVID-19. An enhanced production of secretory immunoglobulin A (sIgA) …
[HTML][HTML] Current diagnostic and therapeutic approaches for severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) and the role of nanomaterial-based …
B Zhang, Q Wu, L Yin, J Zhang, W Gao… - Nanotechnology …, 2023 - degruyter.com
COVID-19 was the most devastating pandemic since the Spanish Flu of 1918, affecting 700
million individuals and causing 6.8 million fatalities globally. COVID-19 vaccines are …
million individuals and causing 6.8 million fatalities globally. COVID-19 vaccines are …